Autolus Therapeutics (AUTL) Enterprise Value (2017 - 2025)
Autolus Therapeutics posted quarterly Enterprise Value of -$105.6 million for Q4 2025, up 53.83% year-on-year from -$68.7 million in Q4 2024, and up 71.25% on a QoQ basis from -$367.4 million in Q3 2025.
Autolus Therapeutics (AUTL) has 9 years of Enterprise Value data on file, last reported at -$105.6 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 53.83% year-over-year to -$105.6 million; the trailing twelve-month figure through Dec 2025 stood at -$105.6 million (up 53.83% YoY), and the FY2025 full-year result was -$105.6 million, up 53.83% from the prior year.
- Enterprise Value for Q4 2025 stood at -$105.6 million, up from -$367.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$97.3 million in Q1 2025 and bottomed at -$759.5 million in Q1 2024.
- The 5-year median for Enterprise Value is -$248.6 million (2023), against an average of -$308.5 million.
- The widest annual swing landed in 2021, when Enterprise Value slumped 39426.21%; it then surged 87.2% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$310.7 million in 2021, then slipped by 23.2% to -$382.8 million in 2022, then soared by 37.21% to -$240.3 million in 2023, then gained by 4.8% to -$228.8 million in 2024, then jumped by 53.83% to -$105.6 million in 2025.
- The last three Enterprise Value figures came in at -$105.6 million (Q4 2025), -$367.4 million (Q3 2025), and -$125.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -105.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105.64 Mn |
| Sep 30, 2025 | -367.42 Mn |
| Jun 30, 2025 | -125.33 Mn |
| Mar 31, 2025 | -97.25 Mn |
| Dec 31, 2024 | -228.81 Mn |
| Sep 30, 2024 | -658.54 Mn |
| Jun 30, 2024 | -706.96 Mn |
| Mar 31, 2024 | -759.54 Mn |
| Dec 31, 2023 | -240.34 Mn |
| Sep 30, 2023 | -256.85 Mn |
| Jun 30, 2023 | -307.83 Mn |
| Mar 31, 2023 | -343.36 Mn |
| Dec 31, 2022 | -382.76 Mn |
| Sep 30, 2022 | -163.37 Mn |
| Jun 30, 2022 | -216.76 Mn |
| Mar 31, 2022 | -268.89 Mn |
| Dec 31, 2021 | -310.68 Mn |
| Sep 30, 2021 | -173.27 Mn |
| Jun 30, 2021 | -216.56 Mn |
| Mar 31, 2021 | -239.80 Mn |
| Dec 31, 2020 | -786,000.00 |
| Sep 30, 2020 | -178.48 Mn |
| Jun 30, 2020 | -212.83 Mn |
| Mar 31, 2020 | -244.10 Mn |
| Dec 31, 2019 | -211.43 Mn |
| Sep 30, 2019 | -230.73 Mn |
| Jun 30, 2019 | -267.56 Mn |
| Mar 31, 2019 | -188.41 Mn |
| Dec 31, 2018 | -217.56 Mn |
| Sep 30, 2018 | -247.19 Mn |
| Jun 30, 2018 | -264.92 Mn |
| Mar 31, 2018 | -120.67 Mn |
| Sep 30, 2017 | -137.07 Mn |